Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02Lester J. Peters, Danny Rischin, Jacques Bernier et al.|Journal of Clinical Oncology|2010Cited by 806
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III TrialDanny Rischin, Grant A. McArthur, Richard J. Young et al.|Journal of Clinical Oncology|2010Cited by 741
Soft tissue sarcomas of adults: state of the translational science.Ernest C. Borden, Murray F. Brennan, Laurence H. Baker et al.|PubMed|2003Cited by 616
Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant MetastasisBrian O’Sullivan, Wei Xu|Journal of Clinical Oncology|2013Cited by 588
Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study GroupAnne W.M. Lee, Joseph T. F. Lau, W.H. Lau et al.|Journal of Clinical Oncology|2005Cited by 448